1. Service Overview & Global Regulatory Compliance Framework
Our end-to-end design and build services deliver full-lifecycle turnkey solutions for pharmaceutical and biopharmaceutical plant construction, fully compliant with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 global quality and data integrity standards. Covering new greenfield plant development, brownfield facility renovation, cleanroom upgrading and utility system reconstruction, our one-stop model serves small-molecule drugs, generic pharmaceuticals, biotherapeutics and vaccine manufacturing facilities for clinical pilot and commercial-scale production. Conventional segmented project execution commonly causes critical pain points including disjointed design and construction logic, inconsistent GMP implementation standards, vendor interface conflicts, incomplete validation documentation and prolonged project delivery cycles. By integrating full-process responsibilities under a single accountable team, we eliminate fragmented technical loopholes and deliver fully audit-ready, regulation-compliant pharmaceutical plants tailored for global market registration and long-term stable operation.
2. Core Service Philosophy & Integrated Delivery Advantages
Guided by quality-by-design (QbD) and risk-based compliance embedding, our design-and-build methodology integrates regulatory requirements, process characteristics and operational efficiency into every engineering stage, rather than applying post-construction rectification. All architectural layout, cleanroom zoning, MEP utility configuration, sanitary equipment layout and automation logic are optimized based on product critical quality attributes (CQAs) and critical process parameters (CPPs), ensuring intrinsic process determinism and contamination control. Adopting unified in-house design standards, standardized construction specifications and self-managed equipment manufacturing resources, we maintain consistent quality control across project phases and eliminate common defects such as non-compliant cleanroom airflow, unqualified sanitary piping layout and mismatched utility load capacity. Compared with traditional separated design-bid-build modes, our integrated delivery shortens overall project schedules, reduces cross-party coordination risks, lowers total CAPEX investment, and ensures inherent GMP compliance and long-term inspection readiness of pharmaceutical facilities.
3. Four Core Integrated Service Modules & Standard Deliverables
Our complete end-to-end pharmaceutical plant design and build system consists of four interconnected full-lifecycle modules covering conceptual planning to final GMP handover: regulatory-aligned plant design module, standardized GMP construction module, integrated equipment & utility implementation module, and commissioning & compliance handover module. The regulatory-aligned design module conducts site feasibility analysis, master plant layout planning, cleanroom classification design, BIM 3D spatial optimization and full-set engineering drawing output, delivering URS, DQ documents and contamination control strategies compliant with global pharmaceutical regulatory expectations. The standardized construction module executes classified cleanroom enclosure, anti-corrosion and sanitary finishing, pressure cascade layout construction and personnel/material flow zoning implementation under strict GMP workmanship supervision. The equipment and utility module integrates sanitary process equipment installation, WFI/PW distribution, HVAC clean air system, CIP/SIP utility network and central automation system deployment with full linkage debugging. The commissioning and handover module completes systematic SAT testing, full-scale IQ/OQ/PQ qualification, electronic batch record configuration and audit-ready document sorting for formal plant commissioning and production release.
4. Industrial Application & Full Lifecycle Technical Support
Our end-to-end design and build solutions are widely applied in commercial pharmaceutical manufacturing parks, GMP standard renovation projects, clinical-grade pilot production plants and multi-product flexible pharmaceutical manufacturing bases targeting global markets. All plant architectures adopt modular scalable design, reserving expandable interfaces for future capacity expansion, product pipeline upgrade and process optimization without large-scale facility reconstruction. We provide full-lifecycle after-delivery support including periodic regulatory standard update training, facility compliance re-assessment, operational technical guidance, deviation troubleshooting and long-term process iteration optimization. Through highly integrated design-and-build execution, we help global pharmaceutical clients achieve rapid, compliant and cost-effective plant construction, shorten production launch cycles, and establish stable, sustainable and audit-ready pharmaceutical manufacturing infrastructure.
